IP Verse

Methods And Medicament For Inhibition The Expression Of A Defined Gene - EP1798285

PATENT ANALYSIS

Patent Details

Grant Date
Mar 15, 2017
Company
ALNYLAM EUROPE AG
Oppositions

SILENCE THERAPEUTICS GMBH

More patents of Alnylam Europe Ag

EP1798285

Want to monitor this patent?

Feel free to send us a message here and we will get back to you